Back to results
US 10,294,233 B2Granted
Treatment of H. pylori infections using MTAN inhibitors
AssigneesAlbert Einstein College of Medicine, Victoria Link Limited
InventorsVern L. Schramm, Keith Clinch, Shivali Ashwin Gulab
Life of this patent
Estimating the term…
Abstract
Methods of treating infections due to Helicobacter pylori (H. pylori), in particular in subjects having a peptic ulcer, are disclosed where the methods comprise administering inhibitors of H. pylori MTAN (5′-methylthioadenosine nucleosidase) to the subject.
Claims2
A compound having the structure
- or a pharmaceutically acceptable salt thereof, or an ester thereof.
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound having the structure
- or a pharmaceutically acceptable salt thereof, or an ester thereof.
Dependencies are inferred from the claim text.